Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Mind Cure Health Inc
(OP:
MCURF
)
N/A
UNCHANGED
Last Price
Updated: 2:36 PM EDT, Sep 11, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Mind Cure Health Inc
< Previous
1
2
3
Next >
Psyched: GH Research Debuts on Nasdaq, Compass Reaches Psilocybin Research Milestone, Maxim Gives BUY Rating to 10 Psychedelics Companies
July 02, 2021
Irish 5-MeO-DMT Company GH Research Debuts On Nasdaq GH Research, a Dublin-based company studying the potential o...
Via
Benzinga
Maxim Group Gives Buy Rating To 10 Psychedelic Stocks: Compass, MindMed, Cybin, Field Trip And More
June 30, 2021
Institutional analysts are taking a liking to the industry ...
Via
Benzinga
Professional Sports Turn To Psychedelics
May 15, 2021
Psychedelic drug R&D is rapidly expanding into many of the largest medical treatment markets.
Via
Talk Markets
Why Smaller Psychedelics Companies Should Start Catching Up To The Sector Leaders
May 05, 2021
Concentration of ownership in psychedelic drug stocks has reached a new extreme. We explain how and why we don't see this trend as being sustainable.
Via
Talk Markets
Psychedelics As A Potential Form Of Treatment For Traumatic Brain Injuries
April 20, 2021
In recent years, there has been a re-emergence in the study of psychedelic drug...
Via
Benzinga
The Next Psychedelic Stock To Uplist On The Nasdaq?
May 04, 2021
As MindMed Inc makes its long-awaited move to the Nasdaq, the obvious question is: who's next?
Via
Talk Markets
Second-Chance Buying Opportunity With Psychedelic Stock Warrants
April 27, 2021
Psychedelic stock warrants delivered epic returns for investors in the big rally in these stocks in 2020. After the pullback in 2021, some of these warrants are again looking attractive.
Via
Talk Markets
Déjà Vu: 2021 Slump In Psychedelic Stocks Mirrors 2020
April 21, 2021
Charts for most psychedelic drug stocks look terrible in recent weeks. The same was true in the summer of 2020 -- immediately before these stocks exploded higher. Deja vu?
Via
Talk Markets
Psychedelic Drugs Market Size Is Projected To Reach $10.75 Billion By 2027
April 21, 2021
Via
FinancialNewsMedia
MINDCURE Partners its iSTRYM Technology with LUCID to Discover and Create Proprietary Music Experiences for Use During Psychedelic-Assisted Therapy Sessions
April 21, 2021
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Cannabis Movers & Shakers: TILT, BRNT, ECGI, Alcanna, WeedMD, Mind Cure, Flowr Corporation, VIVO, Cannabiz, Team Hytiva
April 16, 2021
TILT Holdings Announces Two New Additions To Its Leadership Team TILT Holdings Inc. (CSE:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Psyched: Entheon Launches Psychedelics Genetic Test, Mydecine Unveils Psychedelic Drug Candidates, California Bill Passes Senate Committee
April 12, 2021
Entheon Biomedical Corp. announced the
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.